Matches in SemOpenAlex for { <https://semopenalex.org/work/W3026704906> ?p ?o ?g. }
- W3026704906 endingPage "1875" @default.
- W3026704906 startingPage "1862" @default.
- W3026704906 abstract "// Diana Barea Roldán 1 , * , Matthias Grimmler 2 , 8 , * , Christoph Hartmann 2 , 9 , * , Stefanie Hubich-Rau 1 , * , Tim Beißert 1 , Claudia Paret 2 , 6 , Giuseppe Cagna 3 , 10 , Christoph Rohde 3 , 11 , Stefan Wöll 3 , 4 , Michael Koslowski 2 , 3 , 5 , 12 , Özlem Türeci 2 , 3 , 4 , 7 and Ugur Sahin 1 , 4 , 6 1 TRON–Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany 2 Formerly of TRON–Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany 3 Formerly of Ganymed Pharmaceuticals AG, Mainz, Germany 4 Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany 5 Formerly of University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany 6 University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany 7 Ci3 Cluster for Individualized Immune Intervention, Mainz, Germany 8 Current address: DiaSys Diagnostic Systems GmbH, Holzheim, Germany 9 Current address: Merck KGaA, Darmstadt, Germany 10 Current address: Lonza Pharma & Biotech, Cologne, Germany 11 Current address: Merck KGaA, Darmstadt, Germany 12 Current address: GammaDelta Therapeutics, London, United Kingdom * These authors contributed equally to this work Correspondence to: Ugur Sahin, email: Ugur.Sahin@uni-mainz.DE Keywords: PLAC1; tumorigenesis; extracellular matrix; fibroblast growth factor; AKT Received: November 14, 2019 Accepted: March 14, 2020 Published: May 19, 2020 ABSTRACT PLAC1 (placenta enriched 1) is a mammalian trophoblast-specific protein. Aberrant expression of PLAC1 is observed in various human cancers, where it is involved in the motility, migration, and invasion of tumor cells, which are associated with the phosphoinositide 3-kinase (PI3K)/AKT pathway. We previously demonstrated that AKT activation mediates the downstream effects of PLAC1; however, the molecular mechanisms of PLAC1-induced AKT-mediated tumor-related processes are unclear. We studied human choriocarcinoma and breast cancer cell lines to explore the localization and receptor-ligand interactions, as well as the downstream effects of PLAC1. We show secretion and adherence of PLAC1 to the extracellular matrix, where it forms a trimeric complex with fibroblast growth factor 7 (FGF7) and its receptor, FGF receptor 2 IIIb (FGFR2IIIb). We further show that PLAC1 signaling via FGFR2IIIb activates AKT phosphorylation in cancer cell lines. As the FGF pathway is of major interest in anticancer therapeutic strategies, these data further promote PLAC1 as a promising anticancer drug target." @default.
- W3026704906 created "2020-05-29" @default.
- W3026704906 creator A5000036560 @default.
- W3026704906 creator A5002033232 @default.
- W3026704906 creator A5019486329 @default.
- W3026704906 creator A5019546374 @default.
- W3026704906 creator A5032393166 @default.
- W3026704906 creator A5044167771 @default.
- W3026704906 creator A5045306689 @default.
- W3026704906 creator A5049626418 @default.
- W3026704906 creator A5058129398 @default.
- W3026704906 creator A5058426254 @default.
- W3026704906 creator A5075617216 @default.
- W3026704906 creator A5083688615 @default.
- W3026704906 date "2020-05-19" @default.
- W3026704906 modified "2023-10-15" @default.
- W3026704906 title "PLAC1 is essential for FGF7/FGFRIIIb-induced Akt-mediated cancer cell proliferation" @default.
- W3026704906 cites W14420131 @default.
- W3026704906 cites W1555082791 @default.
- W3026704906 cites W1894751757 @default.
- W3026704906 cites W1930773806 @default.
- W3026704906 cites W1967262117 @default.
- W3026704906 cites W1968744437 @default.
- W3026704906 cites W1971185703 @default.
- W3026704906 cites W1971506156 @default.
- W3026704906 cites W1984160392 @default.
- W3026704906 cites W1988476050 @default.
- W3026704906 cites W1990635229 @default.
- W3026704906 cites W1994904788 @default.
- W3026704906 cites W1999314540 @default.
- W3026704906 cites W2008581828 @default.
- W3026704906 cites W2009214383 @default.
- W3026704906 cites W2015746432 @default.
- W3026704906 cites W2024133424 @default.
- W3026704906 cites W2026389696 @default.
- W3026704906 cites W2027239974 @default.
- W3026704906 cites W2028531522 @default.
- W3026704906 cites W2030613990 @default.
- W3026704906 cites W2038409460 @default.
- W3026704906 cites W2042202567 @default.
- W3026704906 cites W2050580690 @default.
- W3026704906 cites W2056983875 @default.
- W3026704906 cites W2067450274 @default.
- W3026704906 cites W2071927361 @default.
- W3026704906 cites W2087550837 @default.
- W3026704906 cites W2094747124 @default.
- W3026704906 cites W2112466812 @default.
- W3026704906 cites W2124096727 @default.
- W3026704906 cites W2138178479 @default.
- W3026704906 cites W2145817798 @default.
- W3026704906 cites W2149323323 @default.
- W3026704906 cites W2150026213 @default.
- W3026704906 cites W2150382848 @default.
- W3026704906 cites W2150615816 @default.
- W3026704906 cites W2155984740 @default.
- W3026704906 cites W2157459952 @default.
- W3026704906 cites W2186444000 @default.
- W3026704906 cites W2221405021 @default.
- W3026704906 cites W2388163742 @default.
- W3026704906 cites W2604531262 @default.
- W3026704906 cites W2626084459 @default.
- W3026704906 cites W2761693278 @default.
- W3026704906 cites W2797020413 @default.
- W3026704906 cites W2948407805 @default.
- W3026704906 cites W4238753350 @default.
- W3026704906 doi "https://doi.org/10.18632/oncotarget.27582" @default.
- W3026704906 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7244013" @default.
- W3026704906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32499871" @default.
- W3026704906 hasPublicationYear "2020" @default.
- W3026704906 type Work @default.
- W3026704906 sameAs 3026704906 @default.
- W3026704906 citedByCount "6" @default.
- W3026704906 countsByYear W30267049062021 @default.
- W3026704906 countsByYear W30267049062022 @default.
- W3026704906 countsByYear W30267049062023 @default.
- W3026704906 crossrefType "journal-article" @default.
- W3026704906 hasAuthorship W3026704906A5000036560 @default.
- W3026704906 hasAuthorship W3026704906A5002033232 @default.
- W3026704906 hasAuthorship W3026704906A5019486329 @default.
- W3026704906 hasAuthorship W3026704906A5019546374 @default.
- W3026704906 hasAuthorship W3026704906A5032393166 @default.
- W3026704906 hasAuthorship W3026704906A5044167771 @default.
- W3026704906 hasAuthorship W3026704906A5045306689 @default.
- W3026704906 hasAuthorship W3026704906A5049626418 @default.
- W3026704906 hasAuthorship W3026704906A5058129398 @default.
- W3026704906 hasAuthorship W3026704906A5058426254 @default.
- W3026704906 hasAuthorship W3026704906A5075617216 @default.
- W3026704906 hasAuthorship W3026704906A5083688615 @default.
- W3026704906 hasBestOaLocation W30267049061 @default.
- W3026704906 hasConcept C71924100 @default.
- W3026704906 hasConceptScore W3026704906C71924100 @default.
- W3026704906 hasIssue "20" @default.
- W3026704906 hasLocation W30267049061 @default.
- W3026704906 hasLocation W30267049062 @default.
- W3026704906 hasLocation W30267049063 @default.
- W3026704906 hasLocation W30267049064 @default.
- W3026704906 hasOpenAccess W3026704906 @default.
- W3026704906 hasPrimaryLocation W30267049061 @default.